These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 26655238

  • 1. Cell-cell contact promotes Ebola virus GP-mediated infection.
    Miao C, Li M, Zheng YM, Cohen FS, Liu SL.
    Virology; 2016 Jan 15; 488():202-15. PubMed ID: 26655238
    [Abstract] [Full Text] [Related]

  • 2. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
    Brunton B, Rogers K, Phillips EK, Brouillette RB, Bouls R, Butler NS, Maury W.
    PLoS Negl Trop Dis; 2019 Jun 15; 13(6):e0006983. PubMed ID: 31242184
    [Abstract] [Full Text] [Related]

  • 3. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
    Spence JS, Krause TB, Mittler E, Jangra RK, Chandran K.
    mBio; 2016 Feb 09; 7(1):e01857-15. PubMed ID: 26861015
    [Abstract] [Full Text] [Related]

  • 4. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by In Situ Proximity Ligation.
    Mittler E, Alkutkar T, Jangra RK, Chandran K.
    mBio; 2021 Jan 12; 12(1):. PubMed ID: 33436438
    [Abstract] [Full Text] [Related]

  • 5. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE, Chandran K, Saphire EO.
    mBio; 2016 Feb 23; 7(1):e02154-15. PubMed ID: 26908579
    [Abstract] [Full Text] [Related]

  • 6. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.
    J Infect Dis; 2015 Oct 01; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [Abstract] [Full Text] [Related]

  • 7. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
    Martinez O, Ndungo E, Tantral L, Miller EH, Leung LW, Chandran K, Basler CF.
    J Virol; 2013 Mar 01; 87(6):3324-34. PubMed ID: 23302883
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
    Rhein BA, Brouillette RB, Schaack GA, Chiorini JA, Maury W.
    J Virol; 2016 Jul 01; 90(13):6097-6111. PubMed ID: 27122575
    [Abstract] [Full Text] [Related]

  • 17. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
    Acciani MD, Lay Mendoza MF, Havranek KE, Duncan AM, Iyer H, Linn OL, Brindley MA.
    J Virol; 2021 Sep 27; 95(20):e0116521. PubMed ID: 34319156
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
    Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J.
    Nature; 2011 Aug 24; 477(7364):344-8. PubMed ID: 21866101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.